Catalina Capital Group LLC Sells 146 Shares of Intuitive Surgical, Inc. $ISRG

Catalina Capital Group LLC reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.5% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,809 shares of the medical equipment provider’s stock after selling 146 shares during the quarter. Catalina Capital Group LLC’s holdings in Intuitive Surgical were worth $983,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in ISRG. Nuveen LLC bought a new stake in shares of Intuitive Surgical during the 1st quarter valued at about $1,715,899,000. Goldman Sachs Group Inc. increased its position in Intuitive Surgical by 26.1% in the first quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock worth $1,396,496,000 after buying an additional 584,375 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Intuitive Surgical by 20.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock worth $1,680,922,000 after buying an additional 566,979 shares in the last quarter. Wellington Management Group LLP increased its position in Intuitive Surgical by 15.0% in the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after buying an additional 457,080 shares in the last quarter. Finally, Vanguard Group Inc. increased its position in Intuitive Surgical by 1.4% in the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after buying an additional 453,335 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider owned 19,827 shares in the company, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have commented on ISRG shares. Wells Fargo & Company upped their price target on Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 23rd. Piper Sandler restated an “overweight” rating and issued a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Friday, September 26th. BTIG Research reaffirmed a “buy” rating and issued a $571.00 price objective on shares of Intuitive Surgical in a research note on Wednesday. Finally, UBS Group upped their price objective on Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 23rd. Fourteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $594.19.

Intuitive Surgical Trading Up 1.1%

Shares of Intuitive Surgical stock opened at $443.01 on Friday. The stock has a 50 day moving average of $464.42 and a 200 day moving average of $500.22. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The firm has a market cap of $158.81 billion, a PE ratio of 61.79, a PEG ratio of 4.59 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm’s revenue was up 21.4% on a year-over-year basis. During the same period in the prior year, the company earned $1.78 earnings per share. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.